NCT01140568View on ClinicalTrials.gov

Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas

PHASE2CompletedINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

April 21, 2010

Primary Completion Date

October 5, 2016

Study Completion Date

January 31, 2019

Conditions

Glioma

Interventions

DRUG

nilotinib

400mg po (orally) BID (twice daily)

Trial Locations (1)

92093

The Rebecca and John Moores UCSD Cancer Center, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

David Piccioni, M.D., Ph.D

OTHER